Bessemer Group’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3K Buy
199
+165
+485% +$2.49K ﹤0.01% 2161
2025
Q1
$0 Sell
34
-51
-60% ﹤0.01% 2739
2024
Q4
$2K Hold
85
﹤0.01% 2281
2024
Q3
$2K Buy
+85
New +$2K ﹤0.01% 2290